The stage of diagnosis of Prostate Cancer begins with the appointment of an urologist or oncologist. As a rule, by this time the patient suspects the disease according to the parameters of the PSA test, or after a routine examination of the urologist.

The diagnosis of Prostate Cancer is always based on histological findings. For this, a puncture or saturation biopsy is performed.

For the most effective treatment of prostate cancer requires accurate information about the localization of cancer. Therefore, the diagnostic labs use a number of PET-CT examinations, shown in prostate cancer. PET-CT is used not only at the stage of diagnosis, but also when calculating the radiation dosimetry plan and when evaluating the effectiveness of targeted therapy. The specialists of the hospital have a unique experience in the use of PET-CT with radioisotope sensitive to prostate cancer.

This examination determines prostate cancer with low PSA, when cancer spreads to the lymph nodes and is particularly effective in tracking the recurrence of the disease after surgery or radiation therapy. PET-CT with PSMA allows doctors to more accurately conduct diagnostics and select optimal treatment for the patient, taking into account its effectiveness and preservation of quality of life. The information on the exact location of the cancer is extremely important for the surgeon when deciding on the operation.

At the stage of diagnosing prostate cancer, it is important to obtain accurate information about the disease, for further treatment planning.

As part of routine physical examinations, men usually undergo a PSA (Prostatic Specific Antigen) test to test prostate cancer. The moment of truth comes when indicators are high, indicating the possibility of cancer. What to do in this case? Do you want to retake the test? To make a painful biopsy? And the worst thing is- what if the diagnosis is confirmed? Quickly start treatment, at the risk of causing impotence and incontinence?

Still more complicating is the fact that there is no clear consensus among experts on testing and treating prostate cancer. Many of them are generally against the PET CT scan, since the results usually lead to unwanted biopsy and unnecessary treatment.

Prostate cancer develops so slowly that only 15-20% of men are really in danger, but it was still impossible to distinguish between moderate cancer and life-threatening cancer, so we in vain treated somewhere 85% of men, putting them under the threat of impotence and incontinence almost without reason.

Ultrasound can measure the size of the prostate for biopsy, and color Doppler ultrasound captures an increased flow of blood that helps determine the cancer. The new technology also allows you to consider specific suspicious areas for biopsy.

If you have an elevated PSA, experts recommends:

•        Ask your doctor to perform a rectal examination to check if there are any swelling or disturbances and to pass an ultrasound to measure the size of the prostate;
• If there is a suspicion of an infection, take a course of antibiotics and do a repeat PSA test;
•        MRI prostate using 3.0 Tesla. This technology determines cancer tumors with an accuracy of 85-90%, even very tiny, with a size of 5mm.
•        Make color ultrasound dopplerography.
•        Only then make a biopsy using information from MRI and Doppler ultrasound so that doctors can get more accurate results.

If you decide to undergo treatment, get a second opinion and discuss options for robotic prostatectomy, proton radiation and cryotherapy.